ES8300097A1 - "un procedimiento para preparar derivados de halofenil-piridil-alilamina". - Google Patents

"un procedimiento para preparar derivados de halofenil-piridil-alilamina".

Info

Publication number
ES8300097A1
ES8300097A1 ES508065A ES508065A ES8300097A1 ES 8300097 A1 ES8300097 A1 ES 8300097A1 ES 508065 A ES508065 A ES 508065A ES 508065 A ES508065 A ES 508065A ES 8300097 A1 ES8300097 A1 ES 8300097A1
Authority
ES
Spain
Prior art keywords
processes
pharmaceutical preparations
halophenyl
pyridyl
intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES508065A
Other languages
English (en)
Other versions
ES508065A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra Lakemedel AB
Original Assignee
Astra Lakemedel AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Lakemedel AB filed Critical Astra Lakemedel AB
Publication of ES508065A0 publication Critical patent/ES508065A0/es
Publication of ES8300097A1 publication Critical patent/ES8300097A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/48—Aldehydo radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

UN PROCEDIMIENTO PARA PREPARAR DERIVADOS DE HALOFENIL-PIRIDIL-ALILAMINA. CONSISTE EN AMINAR REDUCTORAMENTE UN ALDEHIDO O ACIDO CARBOXILICO DE FORMULA (I) CON METILAMINA O DIMETILAMINA EN PRESENCIA DE UN AGENTE REDUCTOR. SE OBTIENE EL COMPUESTO (II) QUE SI SE DESEA SE TRANSFORMA EN UNA SAL FARMACEUTICAMENTE ACEPTABLE Y/O EN UN ISOMERO E O Z DEL MISMO. R ES H O CH3; N ES 1 O 2, X ES UN HALOGENO TAL COMO F, CLO, BR O I, UNIDO EN UNA POSICION OPCIONAL AL GRUPO FENILO, CON LA CONDICION DE QUE CUANDO X ES BR, ESTE ESTA UNIDO EN UNA POSICION DIFERENTE A LA 4. *FORMULA*. E
ES508065A 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina". Expired ES8300097A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7909514A SE7909514L (sv) 1979-11-16 1979-11-16 Nya halofenyl-pyridyl-allylaminderivat

Publications (2)

Publication Number Publication Date
ES508065A0 ES508065A0 (es) 1982-10-01
ES8300097A1 true ES8300097A1 (es) 1982-10-01

Family

ID=20339337

Family Applications (5)

Application Number Title Priority Date Filing Date
ES496859A Expired ES8204721A1 (es) 1979-11-16 1980-11-14 Un procedimiento para preparar derivados de halofenil-piri- dilalilamina
ES508065A Expired ES8300097A1 (es) 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
ES508064A Expired ES8300096A1 (es) 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
ES508063A Expired ES8300095A1 (es) 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
ES508062A Expired ES8300094A1 (es) 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina".

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES496859A Expired ES8204721A1 (es) 1979-11-16 1980-11-14 Un procedimiento para preparar derivados de halofenil-piri- dilalilamina

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES508064A Expired ES8300096A1 (es) 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
ES508063A Expired ES8300095A1 (es) 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
ES508062A Expired ES8300094A1 (es) 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina".

Country Status (17)

Country Link
US (1) US4418065A (es)
EP (2) EP0029420A1 (es)
JP (1) JPS56501524A (es)
AU (1) AU538087B2 (es)
CA (1) CA1155128A (es)
DK (1) DK300781A (es)
ES (5) ES8204721A1 (es)
FI (1) FI812196L (es)
GR (1) GR72129B (es)
NO (1) NO812401L (es)
NZ (1) NZ195558A (es)
PL (3) PL129369B1 (es)
PT (1) PT72066B (es)
SE (1) SE7909514L (es)
SU (4) SU1103794A3 (es)
WO (1) WO1981001407A1 (es)
ZA (1) ZA807102B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1150269A (en) * 1980-11-14 1983-07-19 Carl B. J. Ulff Process for preparing 3-(4-bromophenyl)-3-(3-pyridyl)-allylamines
US4610995A (en) * 1984-07-27 1986-09-09 Coker Geoffrey G Certain 1,1-diaryl-propenyl-3-(1-pyrrolidino-2-carboxylic acids, derivatives thereof and their anti-histaminic properties
GB8814639D0 (en) * 1988-06-20 1988-07-27 Ici Plc Heterocyclic tertiary alcohol derivatives
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6800652B2 (en) 2002-08-16 2004-10-05 Pfizer Inc. Diaryl compounds
GB0219154D0 (en) * 2002-08-16 2002-09-25 Pfizer Ltd Diaryl compounds
WO2015067923A1 (en) 2013-11-05 2015-05-14 Astrazeneca Ab Nmda antagonist prodrugs

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2676964A (en) * 1950-06-07 1954-04-27 Schering Corp 3-pyridyl propylamine antihistamine substances
DE966534C (de) * 1951-03-22 1957-08-22 Schering Corp Verfahren zur Herstellung von basisch substituierten Pyridinverbindungen
GB850298A (en) 1956-10-30 1960-10-05 Maggioni & C Societa Per Azion ª‡,ª‡[(p-chlorophenyl)-(4-pyridyl)] carbinols and method of preparing same
DE1468359A1 (de) * 1963-10-23 1968-11-28 Merck & Co Inc Verfahren zur Herstellung von Dibenzocycloheptehderivaten
US3396224A (en) * 1965-09-09 1968-08-06 Lilly Co Eli Controlling phytopathogenic fungi on plants with 3-pyridyl methane derivatives
US3423510A (en) * 1966-08-31 1969-01-21 Geigy Chem Corp 3-(p-halophenyl) - 3 - (2'-pyridyl-n-methylpropylamine for the treatment of depression
US3471505A (en) * 1967-02-01 1969-10-07 Ciba Geigy Corp 1-(alkoxyphenyl)-1-(3-pyridyl)-carbinols
SE361663B (es) * 1971-04-28 1973-11-12 Haessle Ab
US3928369A (en) * 1971-04-28 1975-12-23 Haessle Ab Compounds useful as antidepressive agents, and a process for their preparation
US3928613A (en) * 1971-04-28 1975-12-23 Haessle Ab Compounds useful as antidepressive agents
SE373850B (es) 1972-11-16 1975-02-17 Haessle Ab
US4094908A (en) * 1973-08-15 1978-06-13 Richter Gedeon Vegyeszeti Gyar Rt. Alpha-substituted benzhydrol derivatives
GB1480593A (en) * 1973-11-30 1977-07-20 Kefalas As Xanthene and thioxanthene derivatives having pharmaceutical activity
US4102887A (en) * 1974-11-21 1978-07-25 Per Arvid Emil Carlsson Intermediates used in the preparation of phenyl-pyridylamine derivatives
US4186202A (en) * 1974-11-21 1980-01-29 Astra Lakemedel Aktiebolag Phenyl-pyridylamine derivatives
SE388854B (sv) 1974-11-21 1979-03-26 Astra Laekemedel Ab Forfarande for framstellning av fenylpyridylaminderivat
SE418291B (sv) * 1976-05-17 1981-05-18 Astra Laekemedel Ab 4-bromfenyl-3-pyridylderivat som mellanprodukter vid framstellning av fenylpyridylaminer
SE418399B (sv) * 1976-05-21 1981-05-25 Astra Laekemedel Ab Forfarande for framstellning av n,n-dimetyl-3-(4 bromfenyl)-3-(3-pyridyl)allylamin
SE409706B (sv) * 1976-05-21 1979-09-03 Astra Pharma Prod Forfarande for framstellning av n,n-dimetyl-3-(4-bromfenyl)-3-3(3-pyridyl)-allylamin dihydroklorid monohydrat
SE409860B (sv) * 1977-07-04 1979-09-10 Astra Laekemedel Ab En ny mellanprodukt for framstellning av terapeutiskt aktiva pyridinforeningar
EP0000322B1 (en) * 1977-07-04 1982-05-05 Astra Läkemedel Aktiebolag Compounds having an anti-depressive or tranquilizing activity, pharmaceutical compositions containing them, and processes and intermediates for their preparation
SE409861B (sv) * 1977-07-04 1979-09-10 Astra Laekemedel Ab Ett nytt forfarande for framstellning av en terapeutisk aktiv pyridinforening

Also Published As

Publication number Publication date
PT72066A (en) 1980-12-01
US4418065A (en) 1983-11-29
ES508062A0 (es) 1982-10-01
DK300781A (da) 1981-07-07
PL128457B1 (en) 1984-01-31
AU538087B2 (en) 1984-07-26
PL129369B1 (en) 1984-05-31
JPS56501524A (es) 1981-10-22
PT72066B (en) 1982-09-02
ES508064A0 (es) 1982-10-01
PL227849A1 (es) 1981-12-23
ES508063A0 (es) 1982-10-01
ES496859A0 (es) 1982-05-01
PL232731A1 (es) 1982-08-16
ES8300095A1 (es) 1982-10-01
SE7909514L (sv) 1981-05-17
SU1149875A3 (ru) 1985-04-07
NO812401L (no) 1981-07-13
EP0081478A3 (en) 1984-01-04
WO1981001407A1 (en) 1981-05-28
GR72129B (es) 1983-09-16
NZ195558A (en) 1984-07-06
SU1149874A3 (en) 1985-04-07
FI812196L (fi) 1981-07-10
EP0029420A1 (en) 1981-05-27
SU1138021A3 (ru) 1985-01-30
ES8300094A1 (es) 1982-10-01
PL129370B1 (en) 1984-05-31
PL232732A1 (es) 1982-08-16
SU1103794A3 (ru) 1984-07-15
ES8204721A1 (es) 1982-05-01
ZA807102B (en) 1981-07-29
ES8300096A1 (es) 1982-10-01
AU6437880A (en) 1981-05-21
EP0081478A2 (en) 1983-06-15
CA1155128A (en) 1983-10-11
ES508065A0 (es) 1982-10-01

Similar Documents

Publication Publication Date Title
ES483767A1 (es) Procedimiento para producir n-arilsulfonil-l-argininamidas
GR3005315T3 (es)
DE3586794D1 (de) Arzneimittel mit psychotroper wirkung.
IL81002A (en) 3,4-diphenyl-pyrazoline-1-carboxamide derivatives,processes for the preparation thereof and insecticidal and acaricidal compositions containing the same
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
IL57577A (en) 1,2-dihydroquinolin-2-one derivatives,processes for their preparation and pharmaceutical compositions containing the same
FR2515179B1 (es)
ES8606282A1 (es) Un procedimiento de preparar derivados de acidos quinolin- ynaftiridin-carboxilicos
FI944823A (fi) Galantamiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
JPS5665869A (en) Novel 22hydroxyalkyll3*4*55trihydroxyypiperidine compound* its manufacture and drug
ES444870A1 (es) Procedimiento para preparar derivados de oxadiazolinona.
DE3362504D1 (en) 1-carboxyalkanoylindoline-2-carboxylic-acid esters, their preparation, pharmaceutical compositions containing them, and their therapeutic use
ES8300096A1 (es) "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
SE7411243L (es)
GB1169945A (en) Pharmaceutical Compositions containing Diphenylalkyl-amine Derivatives
ES8103112A1 (es) Procedimiento para la obtencion de pseudo-trisacaridos
DE3362260D1 (en) (-)-15-deoxyspergualin, a process for the preparation of the same, and a pharmaceutical composition containing the same
ATE30152T1 (de) 1-methyl-5-nitro-imidazolin-derivate und diese enthaltende therapeutische zusammensetzungen.
ES424274A1 (es) Procedimiento para la preparacion de 2,4-diamino-5-(3',5'- dimetoxi-4'-metoxialcoxibencil)-pirimidinas.
HUT41615A (en) Fungicidal compositions comprising benzaldoxime carbamate derivatives as active substance and process for preparing such compounds
HUT44268A (en) Process for preparing compounds with construction similar to antibiotic tan-749
ES471125A1 (es) Procedimiento para preparar derivados de 1-aminoindolina
ES8103774A1 (es) Un procedimiento para preparar nuevos compuestos de triazeno
IL64218A0 (en) Heterobicyclic hydroximidates and thiolhydroximidates and carbamate ester derivatives thereof,their preparation and their use as pesticides
ES482083A1 (es) Un procedimiento para la preparacion de un derivado de teta-hidro-2h-benzo-c-pirrol.